Area of research
Hematology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Medicine, Internal medicine, Lung cancer, Biology, Apoptosis, and Single-nucleotide polymorphism.
MEF2A, MEF2C, and MEF2D as potential biomarkers of pancreatic cancer?
A case of human diarrhea caused by Gallibacterium anatis: a case report
Identification of the consistently differential expressed hub mRNAs and proteins in lung adenocarcinoma and construction of the prognostic signature: a multidimensional analysis
Venetoclax Combined with Hag Regimen in Newly Diagnosed ETP-ALL: Interim Analysis of a Prospective, Multicenter, Phase 2 Trial
Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial
Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia
Leucine rich alpha-2-glycoprotein 1 (Lrg1) silencing protects against sepsis-mediated brain injury by inhibiting transforming growth factor beta1 (TGFβ1)/SMAD signaling pathway
A Novel apaQTL-SNP for the Modification of Non-Small-Cell Lung Cancer Susceptibility across Histological Subtypes
Antioxidant and immunomodulatory activities of Oviductus ranae in mice
Zinc oxide nanoparticles reduce the chemoresistance of gastric cancer by inhibiting autophagy
A novel regQTL-SNP and the risk of lung cancer: a multi-dimensional study
miRNA sequencing reveals miRNA‐4508 from peripheral blood lymphocytes as potential diagnostic biomarker for silica‐related pulmonary fibrosis: A multistage study
Functional Variant in 3′UTR of <i>FAM13A</i> Is Potentially Associated with Susceptibility and Survival of Lung Squamous Carcinoma
RAGE may act as a tumour suppressor to regulate lung cancer development
TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma
Quantitative assessment of polymorphisms in <i>H19</i> lncRNA and cancer risk: a meta-analysis of 13,392 cases and 18,893 controls
Role of CIP2A in the antitumor effect of bortezomib in colon cancer